This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Banerjee, N. S. Articles by Nettelbeck, D. M. Search for Related Content PubMed PubMed Citation Articles by Banerjee, N. S. Articles by Nettelbeck, D. M.

¹ Department of Biochemistry and Molecular Genetics and ² Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, and Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL and ³ Department of Dermatology, University Medical Center Erlangen, Erlangen, Germany

Requests for Reprints: Dirk M. Nettelbeck, Department of Dermatology, University Medical Center Erlangen, Hartmannstr. 14, 91052 Erlangen, Germany. Phone: 49-9131-853-4746; Fax: 49-9131-853-6417. E-mail: dirk.nettelbeck{at}derma.imed.uni-erlangen.de; or N. Sanjib Banerjee, Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, 585 MCLM Bldg., 1918 University Blvd., Birmingham, AL 35294-0005. Phone: (205) 975-8304; Fax: (205) 975-6075. E-mail: banerjee{at}uab.edu

We have generated novel conditionally replicative adenoviruses (CRAds) targeted to melanoma cells. In these adenoviruses, the E4 region (Ad24TyrE4) or both E1 and E4 regions (Ad2xTyr) were controlled by a synthetic tyrosinase enhancer/promoter (Tyr2E/P) specific for melanocytes. The properties of these CRAds were compared with wild-type adenovirus (Adwt) and our previous CRAd with a targeted E1A CRII mutation (AdTyr24) in submerged cultures of melanoma cells and nonmelanoma control cells. We showed that Ad24TyrE4 had a cell type selectivity similar to AdTyr24 but had a distinct block in viral reproduction in nonmelanoma cells and that Ad2xTyr had an augmented selectivity for melanoma cells. These viruses were additionally tested in organotypic cultures of melanoma cell lines, primary human keratinocytes (PHKs), or mixed cell populations. Unexpectedly, the CRAds exhibited somewhat different cell type selectivity profiles in these cultures relative to those observed in submerged cultures, demonstrating the importance of multiple assay systems. Specifically, AdTyr24 and Ad2xTyr were selective for melanoma cells, whereas Ad24TyrE4 exhibited no selectivity, similar to Adwt. AdTyr24 and Ad2xTyr were strongly attenuated in their ability to lyse PHKs in organotypic cultures. Furthermore, Ad2xTyr had a superior melanoma selectivity in organotypic cultures of cocultivated melanoma cells and PHKs. The enhanced selectivity for melanoma cells exhibited by Ad2xTyr provides a window of opportunity for therapeutic application. These studies also demonstrate that organotypic cultures derived from mixtures of tumor and normal cells represent a promising new model for analysis of CRAd specificity and toxicity.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Note: N.S. Banerjee and A. Rivera contributed equally to this work.

⁴ Supplemental material is available for this article at Molecular Cancer Therapeutics online (http://mct.aacrjournals.org).

Received 10/22/03; revised 1/ 8/04; accepted 2/ 6/04.

This article has been cited by other articles:

				A. M. Sonabend, I. V. Ulasov, M. A. Tyler, A. A. Rivera, J. M. Mathis, and M. S. Lesniak Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma Stem Cells, March 1, 2008; 26(3): 831 - 841. [Abstract] [Full Text] [PDF]

				A. Hesse, D. Kosmides, R. E. Kontermann, and D. M. Nettelbeck Tropism Modification of Adenovirus Vectors by Peptide Ligand Insertion into Various Positions of the Adenovirus Serotype 41 Short-Fiber Knob Domain J. Virol., March 15, 2007; 81(6): 2688 - 2699. [Abstract] [Full Text] [PDF]

				D. Hoffmann and O. Wildner Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy. Mol. Cancer Ther., August 1, 2006; 5(8): 2013 - 2022. [Abstract] [Full Text] [PDF]

				J. M. Mathis, P. L. Stewart, Z. B. Zhu, and D. T. Curiel Advanced Generation Adenoviral Virotherapy Agents Embody Enhanced Potency Based upon CAR-Independent Tropism. Clin. Cancer Res., May 1, 2006; 12(9): 2651 - 2656. [Full Text] [PDF]

				D. Hoffmann and O. Wildner Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment. Mol. Cancer Ther., February 1, 2006; 5(2): 374 - 381. [Abstract] [Full Text] [PDF]

				X. Li, Y.-P. Zhang, H.-S. Kim, K.-H. Bae, K. M. Stantz, S.-J. Lee, C. Jung, J. A. Jimenez, T. A. Gardner, M.-H. Jeng, et al. Gene Therapy for Prostate Cancer by Controlling Adenovirus E1a and E4 Gene Expression with PSES Enhancer Cancer Res., March 1, 2005; 65(5): 1941 - 1951. [Abstract] [Full Text] [PDF]